Orchid chemicals shares buoyant

Stock markets in today’s trading in shares of orchids Chemicals trend looks fast. Bombay Stock Exchange (BSE) at 11.44 this morning the company’s share price climbed 9.6% to 138.70 crore. Although it upwards before it went to Rs 141.65. Chennai – based pharmaceutical company, orchid chemicals and the release sent today Formasyutikals Ltd has informed BSE that the U.S. Food and Drug Administration Piparisilin and injections Tejobaktm Department (U.S. FDA) has secured approval from Aandia.

It is believed that the U.S. FDA approval of these products ask orchids Chemicals is the first applicant company and this company for 180 days of marketing for these products Exclusive rights are also given. Chemicals in the U.S. market for these drugs Apoteks orchids together Utaregi.

In the first week of August by the company were issued in the quarter ended June 30 standalone results according to the Abita 27.6 crore, while the corresponding quarter last year it was Rs 57.15 Abita. April-June quarter of 2009 its total income was Rs 308.83 crore while its total income in the same period last year was Rs 306.32 crore.

No related posts.